Ten years after the Rx-to-OTC switch of nicotine replacement therapy: What have we learned about the benefits and risks of non-prescription availability?
Year: 2007
Type: review
Source: Health Policy
Authors: Saul Shiffman, Christine T. Sweeney
Institution: Pinney Associates (United States)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: GlaxoSmithKline
OpenAlex ID: W2008165838
